SynthesisZeitschrift fur Rheumatologie2026

Comparative efficacy and safety of denosumab biosimilar and originator in postmenopausal osteoporosis: a meta-analysis of randomized controlled trials.

Young Ho Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.